Schedule 13G ownership disclosure

ALDER BIOPHARMACEUTICALS INC

Security class unavailable · CUSIP: 014339105

Event date: 2019-02-28

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
10,338,850
Percent of class
12.6700%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902219-19-000408
Form type
SC 13G/A
Filer
ALDER BIOPHARMACEUTICALS INC
CIK
CIK 1423824
Filed
Mar 11, 2019
Reporting period
Feb 28, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub